 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 3958 | 回復(fù): 16 | ||||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | ||||
wachina至尊木蟲 (知名作家)
|
[交流]
武田fasiglifam (TAK-875)宣告失敗，恒瑞呋格列泛齒亡唇寒 已有16人參與
|
|||
|
Takeda terminates development activities for fasiglifam (TAK-875) Takeda Pharmaceutical Company Limited (Takeda) announced that it has decided voluntarily to terminate the development activities for fasiglifam (TAK-875), an investigational treatment for type 2 diabetes, due to concerns about liver safety. Patient safety is Takeda's highest priority. The company has worked with three independent panels of experts to provide for the safety of trial participants and ensure independent safety oversight for the clinical trials throughout the duration of the fasiglifam (TAK-875) Phase 3 development program. The expert panels include the independent Data Monitoring Committee (DMC), a committee that oversees the fasiglifam global clinical development program, reviews the unblinded clinical data from program trials and provides continual safety oversight of trial subjects and recommendations. The DMC is comprised of clinical experts in endocrinology, cardiology and hepatology as well as a statistician. The independent Liver Safety Evaluation Committee (LSEC) is comprised of five hepatologists with expertise in drug-induced liver injury. While remaining blinded to treatment information, the LSEC regularly evaluates data on liver enzymes elevations and adjudicates cases that impacted the liver. In addition, an independent Executive Committee (EC) provides additional oversight for the fasiglifam (TAK-875) cardiovascular outcomes trial. After careful consideration of the data emerging from all the clinical trials and in consultation with these panels, the company has reached the conclusion that, on balance, the benefits of treating patients with fasiglifam (TAK-875) do not outweigh the potential risks. For this reason, Takeda has decided voluntarily to terminate the development activities for fasiglifam. 作為慢性疾�。禾悄虿〉闹委煟味拘蕴旅�，難怪武田揮淚斬馬謖。值得一提的是，恒瑞也向CFDA申報了GPR-40激動劑呋格列泛，現(xiàn)在心里估計也是拔涼拔涼的 |
回復(fù)此樓» 收錄本帖的淘帖專輯推薦
 新藥仿藥 |
» 猜你喜歡
點(diǎn)亮模型第16期 | 博萊霉素致大鼠間質(zhì)性肺病模型的構(gòu)建
已經(jīng)有0人回復(fù)
-
干貨分享 ｜PCR和凝膠電泳實驗結(jié)果常見問題及原因分析
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有208人回復(fù)
-
文獻(xiàn)分享 | 關(guān)于T細(xì)胞的相關(guān)研究
已經(jīng)有5人回復(fù)
-
文獻(xiàn)分享 | Nature綜述：中山大學(xué)團(tuán)隊闡述靶向腫瘤活性氧（ROS）的原理與策略
已經(jīng)有5人回復(fù)
-
生防菌的盆栽防效實驗
已經(jīng)有1人回復(fù)
-
請教大佬擴(kuò)散問題
已經(jīng)有5人回復(fù)
-
中文投稿“腫瘤免疫”相關(guān)
已經(jīng)有6人回復(fù)
-
2025年藥學(xué)專業(yè)求調(diào)劑
已經(jīng)有1人回復(fù)
-
292藥學(xué)調(diào)劑
已經(jīng)有1人回復(fù)
lu198799
金蟲 (正式寫手)
- 應(yīng)助: 7 (幼兒園)
- 金幣: 1362.5
- 散金: 2
- 帖子: 454
- 在線: 127.5小時
- 蟲號: 775421
- 注冊: 2009-05-20
- 性別: GG
- 專業(yè): 合成藥物化學(xué)
9樓2013-12-31 10:00:56
2樓2013-12-30 12:41:43
guri
鐵蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 74
- 帖子: 6
- 在線: 9.6小時
- 蟲號: 2285814
- 注冊: 2013-02-18
- 性別: GG
- 專業(yè): 藥物設(shè)計與藥物信息
3樓2013-12-30 13:06:43
wph75623
銅蟲 (小有名氣)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 159.9
- 帖子: 137
- 在線: 54.9小時
- 蟲號: 1922830
- 注冊: 2012-08-03
- 專業(yè): 合成藥物化學(xué)
4樓2013-12-30 16:49:55
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 081700化工學(xué)碩調(diào)劑 +3 | 【1】 2026-03-16 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研]
 320求調(diào)劑0856
+3
|
不想起名字112 2026-03-19 | 3/150 |
|
|
|
[考研] 一志愿北京化工大學(xué)0703化學(xué)318分，有科研經(jīng)歷，求調(diào)劑 +3 | 一瓶苯甲酸 2026-03-14 | 3/150 |
|
|
[考研] 一志愿天津大學(xué)化學(xué)工藝專業(yè)（081702）315分求調(diào)劑 +11 | yangfz 2026-03-17 | 11/550 |
|
|
|
[考研] 化學(xué)求調(diào)劑 +3 | 臨澤境llllll 2026-03-17 | 4/200 |
|
|
|
[考研] 0703化學(xué)調(diào)劑 +5 | pupcoco 2026-03-17 | 8/400 |
|
|
|
[考研] 281求調(diào)劑（0805） +9 | 煙汐憶海 2026-03-16 | 19/950 |
|
|
|
[考研] 一志愿天大材料與化工（085600）總分338 +5 | 蔡大美女 2026-03-13 | 5/250 |
|
|
|
[考研] 一志愿985，本科211，0817化學(xué)工程與技術(shù)319求調(diào)劑 +10 | Liwangman 2026-03-15 | 10/500 |
|
|
|
[考研] 274求調(diào)劑 +6 | S.H1 2026-03-18 | 6/300 |
|
|
|
[考研] 312求調(diào)劑 +8 | 陌宸希 2026-03-16 | 9/450 |
|
|
|
[考研] 304求調(diào)劑 +12 | 小熊joy 2026-03-14 | 13/650 |
|
|
|
[考研]
0854，計算機(jī)類招收調(diào)劑
+3
|
胡辣湯放糖 2026-03-15 | 6/300 |
|
|
|
[考研] 生物學(xué)071000 329分求調(diào)劑 +3 | 我愛生物生物愛?/a> 2026-03-17 | 3/150 |
|
|
|
[考研] 0703化學(xué)336分求調(diào)劑 +6 | zbzihdhd 2026-03-15 | 7/350 |
|
|
|
[考研] 268求調(diào)劑 +8 | 一定有學(xué)上- 2026-03-14 | 9/450 |
|
|
|
[考研] 275求調(diào)劑 +4 | 太陽花天天開心 2026-03-16 | 4/200 |
|
|
|
[考研] 288求調(diào)劑 +4 | 奇點(diǎn)0314 2026-03-14 | 4/200 |
|
|
|
[考研] 080500，材料學(xué)碩302分求調(diào)劑學(xué)校 +4 | 初識可樂 2026-03-14 | 5/250 |
|
|
|
[考研] 328求調(diào)劑 +3 | 5201314Lsy！ 2026-03-13 | 6/300 |
|